These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19544693)

  • 1. Adjuvant or induction cisplatin-based chemotherapy for operable lung cancer.
    Besse B; Le Chevalier T
    Oncology (Williston Park); 2009 May; 23(6):520-7. PubMed ID: 19544693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question?
    Strauss GM
    Oncology (Williston Park); 2009 May; 23(6):534-6, 538. PubMed ID: 19544695
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
    Burfeind WR; Harpole DH
    Semin Thorac Cardiovasc Surg; 2005; 17(3):186-90. PubMed ID: 16253820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for non-small cell lung cancer.
    Pinder-Schenck M; Bepler G
    Minerva Chir; 2009 Dec; 64(6):611-28. PubMed ID: 20029358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger S; Schlemmer M; Heinemann V; Stemmler HJ
    Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for non-small cell lung cancer.
    Bria E; Cuppone F; Cecere FL; Milella M; Nisticò C; Cognetti F; Terzoli E
    J Thorac Oncol; 2007 May; 2(5 Suppl):S7-11. PubMed ID: 17457237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential combined modality therapy for stage III non-small cell lung cancer.
    Vokes EE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.
    Song WA; Zhou NK; Wang W; Chu XY; Liang CY; Tian XD; Guo JT; Liu X; Liu Y; Dai WM
    J Thorac Oncol; 2010 Apr; 5(4):510-6. PubMed ID: 20107424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.